mgawn1
mAbexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2007 (NCT00515385)
Timeline
Indications
Mechanism of action
- West Nile virusINHIBITOR
West Nile virus inhibitor
- E proteinINHIBITOR
E protein inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109625 ↗
Also known as
- mgawn1
- mgawn1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01206504 | N/A | Sep 17, 2010 | MacroGenics, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00927953 | Phase 2 | May 1, 2009 | MacroGenics, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00515385 | Phase 1 | Aug 1, 2007 | MacroGenics, National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MacroGenics | For profit | 3 | 3 | 3 | 2007 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 3 | 0 | 3 | 2007 |
2 organizations
Page 1 / 1